ArticleAIDS patient care and STDs2015
Evaluation of Pharmacy-Based HIV Testing in a High-Risk New York City Community.
Article in AIDS patient care and STDs, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.
- The Role of Pharmacies in the HIV Prevention and Care Continuums: A Systematic Review.AIDS and behavior · 2021Pooled it
- Pharmacy Intervention to Improve HIV Testing Uptake Using a Comprehensive Health Screening Approach.Public health reports (Washington, D.C. : 1974)Trial
- Evaluation of a Collaborative Practice Agreement Intervention to Improve Access to HIV Prevention Services in Southeastern US Pharmacies: Protocol for a Hybrid Type 1 Effectiveness-Implementation Study.JMIR research protocols · 2026Article
- Improving Access to HIV Prevention Services in Community Pharmacies in the US Southeast: Protocol for a Hybrid Type 1 Effectiveness-Implementation Study.JMIR research protocols · 2025Article
- Investigating the potential accessibility to HIV pre-exposure prophylaxis via community pharmacies and sexual health clinics: a scoping review of two integrated care systems in London.BMC health services research · 2025Article
- Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States.Current HIV/AIDS reports · 2024Review
- ASAP: A pharmacy-level intervention to increase nonprescription syringe sales to reduce bloodborne illnesses.Research in social & administrative pharmacy : RSAP · 2024Article
- Community pharmacies: Key players in point-of-care diagnostics for STI screening in Africa.PloS one · 2024Article
- Article
- Point-of-care HIV and hepatitis screening in community pharmacies: a quantitative and qualitative study.International journal of clinical pharmacy · 2022Article
- Integrating and Disseminating Pre-Exposure Prophylaxis (PrEP) Screening and Dispensing for Black Men Who Have Sex With Men in Atlanta, Georgia: Protocol for Community Pharmacies.JMIR research protocols · 2022Article
- Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations - Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine.Current HIV/AIDS reports · 2021Review
- Willingness to Discuss and Screen for Pre-Exposure Prophylaxis in Pharmacies Among Men Who Have Sex With Men.Journal of pharmacy practice · 2021Article
- Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.BMC public health · 2020Article
- Pharmacy Education Needs to Address Diagnostic Safety.American journal of pharmaceutical education · 2019Article
- Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States.Journal of acquired immune deficiency syndromes (1999) · 2018Review
- Feasibility of reaching populations at high risk for HIV in community pharmacies.Journal of the American Pharmacists Association : JAPhAArticle
- Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men.Journal of the American Pharmacists Association : JAPhAArticle
- Examining pharmacies' ability to increase pre-exposure prophylaxis access for black men who have sex with men in the United States.Journal of the American Pharmacists Association : JAPhAArticle
- Assessing pharmacy workflow to enhance the integration of HIV prevention services.Journal of the American Pharmacists Association : JAPhAArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 4 institutions in 1 country.
Funding
Abstract
Blacks/Hispanics face limited access to HIV testing. We examined in-pharmacy HIV testing among customers in pharmacies participating in a nonprescription syringe program in New York City. Participants were recruited in two pharmacies to complete a survey and receive an optional HIV test. Bivariate and multivariable analyses were performed to examine associations of demographics and risk behaviors with receiving in-pharmacy HIV testing. Most participants were male (55%), black (80%), had used hard drugs (88%), and 39.5% received in-pharmacy HIV testing. Being female (AOR=2.24; 95%CI 1.24-4.05), having multiple sex partners (AOR=1.20; 95% CI 1.06-1.35), having an HIV test more than 12 months ago (AOS=4.06; CI 1.85-8.91), injecting drugs in last 3 months (AOR=2.73; 95% CI 1.31-5.69) and having continuous care (AOR=0.32; 95% CI 0.17-0.58) were associated with receiving in-pharmacy HIV test. These data provide evidence of in-pharmacy HIV testing reaching persons at risk of HIV. HIV testing in pharmacies may complement existing strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.